BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
Go back to BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program| Bank of Commerce (NASDAQ: ONC) | Delayed: 351.00 -0.48 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $351.48 | 52 Week High | $0.35 | |||
| Open | $347.82 | 52 Week Low | $0.35 | |||
| Day High | $351.94 | P/E | N/A | |||
| Day Low | $346.17 | EPS | $0.00 | |||
| Volume | 674,731 | |||||

